CIK 0001957132
SN SharkNinja, Inc.
Insider trading from SEC Form 4. Last filing 28 h ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
2
with a Form 4 at this company
Signals
Open-market buys and sells at SharkNinja, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Congressional trades
1 trade in SN disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Val T. Hoyle House · D-OR | Sale | SN SharkNinja, Inc. Ordinary Shares | $1,001 to $15k | Sep 23, 2025 | 17 days after the trade |
Transactions
The last 6 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Shah Neil B. Chief Commercial Officer | MOption exercise Ordinary Shares | +20,000 | $0.00 | $0 | 20,000 | 28 h ago |
| Oct 9, 2026 | Shah Neil B. Chief Commercial Officer | FTax withholding Ordinary Shares | -9,670 | $184.98 | $1.8M | 10,330 | 28 h ago |
| Oct 9, 2026 | Shah Neil B. Chief Commercial Officer | MOption exercise Restricted Share Unitsderivative | -20,000 | $0.00 | $0 | 40,000 | 28 h ago |
| Oct 9, 2026 | Barrocas Mark Chief Executive Officer | MOption exercise Ordinary Shares | +100,000 | $0.00 | $0 | 1,717,959 | 28 h ago |
| Oct 9, 2026 | Barrocas Mark Chief Executive Officer | FTax withholding Ordinary Shares | -39,350 | $184.98 | $7.3M | 1,678,609 | 28 h ago |
| Oct 9, 2026 | Barrocas Mark Chief Executive Officer | MOption exercise Restricted Share Unitsderivative | -100,000 | $0.00 | $0 | 200,000 | 28 h ago |
Insiders
Everyone who has filed a Form 4 here.
- Barrocas MarkChief Executive Officer
- Shah Neil B.Chief Commercial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.